CTCBIO Inc. (KOSDAQ:060590)
South Korea · Delayed Price · Currency is KRW 2,855.00
+15.00 (0.53%)
At close: Jul 21, 2026
CTCBIO Market Cap
CTCBIO has a market cap or net worth of 68.26 billion as of July 21, 2026. Its market cap has decreased by -57.20% in one year.
Market Cap
68.26B
Enterprise Value
91.95B
Revenue
128.76B
Ranking
n/a
PE Ratio
11.10
Stock Price
2,855.00
ChartMarket Cap Chart
Since March 3, 2003, CTCBIO's market cap has increased from 10.66B to 68.26B, an increase of 540.54%. That is a compound annual growth rate of 8.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 68.26B | -38.27% |
| Dec 30, 2025 | 110.58B | -29.39% |
| Dec 30, 2024 | 156.60B | -38.79% |
| Dec 28, 2023 | 255.82B | 69.84% |
| Dec 29, 2022 | 150.63B | -28.80% |
| Dec 30, 2021 | 211.56B | 32.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 77.81B |
| BIO-FD&C | 71.39B |
| SunBio,Inc. | 69.75B |
| QuadMedicine | 68.20B |
| EyeGene | 64.11B |
| AriBioLab | 64.05B |
| PanGen Biotech | 61.69B |
| KoBioLabs | 59.81B |